Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all synonyms
Select your origin of interest
This study demonstrated that Distribution of the GSTO1 alleles and genotypes was nearly equal between the control group and SCA2 (show LY6E Proteins) patients. GSTO1 genotypes were not associated to clinical markers in SCA2 (show LY6E Proteins) patients.
GSTO1 genetic polymorphisms are associated with the progression of HBV infection.
GSTP1 (show GSTP1 Proteins) and GSTO1 polymorphisms are associated with epirubicin treatment outcomes as well as with epirubicin-related toxicity.
No significant association has been found between childhood Pre-B acute lymphoblastic leukemia and GSTO1 A140D and GSTO2 (show GSTO2 Proteins) N142D polymorphisms.
The present study provided epidemiological evidence for a significantly increased risk of UCB in ever smokers with the Ala/Ala genotype of the GSTO1 gene and the Arg/Arg genotype of the SULT1A1 gene.
Our results indicate that GSTO1*C/GSTO2 (show GSTO2 Proteins)*G haplotype is associated with increased risk of TCC (show SFXN1 Proteins). The modifying effect of GSTO2 (show GSTO2 Proteins)*G/G genotype on individual susceptibility to TCC (show SFXN1 Proteins) is more pronounced, when associated with smoking.
This meta-analysis demonstrates that GSTO2 (show GSTO2 Proteins) polymorphism may significantly increase cancer risk in Caucasian population and is associated with elevated risk of breast cancer; while GSTO1 polymorphism is not associated with cancer risk.
Our study is the first to show that the frequency of GSTO1 A140D gene polymorphism in the Turkish population is similar to other Caucasian populations and that this polymorphism is not associated with susceptibility to NSCLC.
Overexpression of GSTO1 is associated with esophageal squamous cell carcinoma.
GSTT1 (show GSTT1 Proteins) active genotype and GSTO1 Asp140Asp and GSTO2 (show GSTO2 Proteins) Asp142Asp genotypes may have a prognostic/pharmacogenomic role in patients with muscle invasive bladder cancer.
Data indicate that GSTO1-1 is required for LPS (show TLR4 Proteins)-mediated signalling in macrophages and that it acts early in the LPS-TLR4 (show TLR4 Proteins) pro-inflammatory pathway.
shRNA knockdown of GSTO1-1 in macrophage-like J774.1A cells blocks the expression of NADPH oxidase 1 (show NOX3 Proteins) and the generation of reactive oxygen species after Bacterial lipopolysaccharide stimulation.
Genes encoding the antioxidants GPX2 (show GPX2 Proteins) and GSTO 1-1 are common inflammatory genes expressed upon induction of allergic airway inflammation, and independently of allergic susceptibility.
The protein encoded by this gene is an omega class glutathione S-transferase (GST) with glutathione-dependent thiol transferase and dehydroascorbate reductase activities. GSTs are involved in the metabolism of xenobiotics and carcinogens. The encoded protein acts as a homodimer and is found in the cytoplasm. Three transcript variants encoding different isoforms have been found for this gene.
glutathione S-transferase omega-1
, glutathione transferase omega-1
, glutathione S-transferase omega 1
, glutathione-S-transferase omega 1
, glutathione S-transferase O1
, GSTO 1-1
, MMA(V) reductase
, S-(Phenacyl)glutathione reductase
, glutathione S-transferase omega 1-1
, glutathione-dependent dehydroascorbate reductase
, monomethylarsonic acid reductase
, glutathione-S-transferase like
, Glutathione transferase omega 1 (GSTO 1-1) (p28)
, glutathione S-transferase like